within Pharmacolibrary.Drugs.L_AntineoplasticAndImmunomodulatingAgents.L01D_CytotoxicAntibioticsAndRelatedSubstances.L01DB06_Idarubicin;
model Idarubicin 
   extends Pharmacolibrary.Drugs.ATC.L.L01DB06;

  annotation(Documentation(
    info ="<html><body><p>Idarubicin is an anthracycline antineoplastic agent used primarily in the treatment of acute myeloid leukemia (AML) in adults and children. It is a cytotoxic antibiotic that intercalates into DNA, disrupting DNA replication and repair. Idarubicin is approved for medical use in several countries and remains a standard treatment in combination chemotherapy regimens for hematological malignancies.</p><h4>Pharmacokinetics</h4><p>Pharmacokinetic parameters in adult patients with acute leukemia following intravenous administration. Population PK studies most frequently report two-compartmental models.</p><h4>References</h4><ol><li><p>Robert, J (1993). Clinical pharmacokinetics of idarubicin. <i>Clinical pharmacokinetics</i> 24(4) 275–288. DOI:<a href=&quot;https://doi.org/10.2165/00003088-199324040-00002&quot;>10.2165/00003088-199324040-00002</a>  PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/8491056/&quot;>https://pubmed.ncbi.nlm.nih.gov/8491056</a></p></li><li><p>Eksborg, S, et al., &amp; Antila, K (1990). Plasma pharmacokinetics of Idarubicin and its 13-hydroxymetabolite after intravenous and oral administration under fasting and non-fasting conditions. <i>Acta oncologica (Stockholm, Sweden)</i> 29(7) 921–925. DOI:<a href=&quot;https://doi.org/10.3109/02841869009096390&quot;>10.3109/02841869009096390</a>  PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/2261209/&quot;>https://pubmed.ncbi.nlm.nih.gov/2261209</a></p></li><li><p>Gillies, HC, et al., &amp; Harper, PG (1987). Pharmacokinetics of idarubicin (4-demethoxydaunorubicin; IMI-30; NSC 256439) following intravenous and oral administration in patients with advanced cancer. <i>British journal of clinical pharmacology</i> 23(3) 303–310. DOI:<a href=&quot;https://doi.org/10.1111/j.1365-2125.1987.tb03049.x&quot;>10.1111/j.1365-2125.1987.tb03049.x</a>  PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/3471265/&quot;>https://pubmed.ncbi.nlm.nih.gov/3471265</a></p></li></ol></body></html>",
    revisions = "<html><body><ul><li>06/2025 model generated by LLM gpt-4.1, references by scholarly and scripts created by Tomas Kulhanek</li></ul></body></html>",
    experiment(StartTime = 0, StopTime = 86400, Tolerance = 1e-09, Interval = 1)
  ));  
end Idarubicin;
